Exsilio Therapeutics
NEW YORK, New York, United States · Healthcare, Health Care
Exsilio Therapeutics is developing genomic medicines that can be delivered in lipid nanoparticles to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions. Exsilio’s technology is based on naturally occurring genetic elements that can precisely insert new genes into a cell through RNA intermediate templates. Exsilio uses predictive in sil
Key facts
- Headquarters
- NEW YORK, New York, United States
- Employees
- 41
- Industries
- Healthcare, Health Care
- Status
- Private
- Website
- avernatx.com
- Company page
Recent activity at Exsilio Therapeutics
Exsilio Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2024 | Series A | $82.0M |
Leadership
- Jake Olin, Vice President
- Tom Barnes, Chief Executive Officer
- Henry Chen, Board Member
- Tal Zaks, Chairman
- Tal Zaks, M.D., Ph.D., Director
- Alex Harding, Director
- Anat Nursella, Executive Officer
- Stephen Squinto, Director
- Roy Amariglio, Executive Officer
Verified email and direct lines for Exsilio Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Exsilio Therapeutics in the news
Companies similar to Exsilio Therapeutics
- Circle Pharma · Healthcare, Health Care
- SpyGlass Pharma, Inc. · Healthcare, Health Care
- iotaMotion · Healthcare, Health Care
- Vektor Medical · Healthcare, Health Care
- ImmersiveTouch · Healthcare, Health Care
About Exsilio Therapeutics: questions and answers
What does Exsilio Therapeutics do?
Exsilio Therapeutics is developing genomic medicines that can be delivered in lipid nanoparticles to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions. Exsilio’s technology is based on naturally occurring genetic elements that can precisely insert new genes into a cell through RNA intermediate templates. Exsilio uses predictive in sil
Where is Exsilio Therapeutics headquartered?
Exsilio Therapeutics is headquartered in NEW YORK, New York, United States.
How many employees does Exsilio Therapeutics have?
Exsilio Therapeutics has about 41 employees.
Has Exsilio Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Exsilio Therapeutics. The most recent, Series A of $82.0M, was in Jun 2024.
Who leads Exsilio Therapeutics?
Jake Olin is a Vice President at Exsilio Therapeutics.
What is the latest news on Exsilio Therapeutics?
On Mar 20, 2026, Exsilio Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy